C. M Stein, M.B.Ch.B.

Official Affiliation: Pharmacology

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

  1. Effects of anti-tumor necrosis factor α agents on bone. Kawai VK, Stein CM, Perrien DS, Griffin MR (2012) Curr Opin Rheumatol 24(5): 576-85
    › Primary publication · 22810364 (PubMed) · PMC3753172 (PubMed Central)
  2. High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation. Bradham WS, Bian A, Oeser A, Gebretsadik T, Shintani A, Solus J, Estis J, Lu QA, Todd J, Raggi P, Stein CM (2012) PLoS One 7(6): e38930
    › Primary publication · 22761714 (PubMed) · PMC3386265 (PubMed Central)
  3. Azithromycin and the risk of cardiovascular death. Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM (2012) N Engl J Med 366(20): 1881-90
    › Primary publication · 22591294 (PubMed) · PMC3374857 (PubMed Central)
  4. CYP2A6 genetic variation and dexmedetomidine disposition. Kohli U, Pandharipande P, Muszkat M, Sofowora GG, Friedman EA, Scheinin M, Wood AJ, Ely EW, Tyndale RF, Choi L, Stein CM, Kurnik D (2012) Eur J Clin Pharmacol 68(6): 937-42
    › Primary publication · 22271297 (PubMed) · PMC3352974 (PubMed Central)
  5. Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise. Ghimire LV, Kohli U, Li C, Sofowora GG, Muszkat M, Friedman EA, Solus JF, Wood AJ, Stein CM, Kurnik D (2012) Pharmacogenet Genomics 22(4): 254-60
    › Primary publication · 22258110 (PubMed) · PMC3303991 (PubMed Central)
  6. Modeling drug exposure data in electronic medical records: an application to warfarin. Liu M, Jiang M, Kawai VK, Stein CM, Roden DM, Denny JC, Xu H (2011) AMIA Annu Symp Proc : 815-23
    › Primary publication · 22195139 (PubMed) · PMC3243123 (PubMed Central)
  7. Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis. Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchel EF, Stein CM, Griffin MR (2011) Arthritis Care Res (Hoboken) 63(10): 1415-24
    › Primary publication · 22121511 (PubMed) · PMC3227007 (PubMed Central)
  8. The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. Birdwell KA, Grady B, Choi L, Xu H, Bian A, Denny JC, Jiang M, Vranic G, Basford M, Cowan JD, Richardson DM, Robinson MP, Ikizler TA, Ritchie MD, Stein CM, Haas DW (2012) Pharmacogenet Genomics 22(1): 32-42
    › Primary publication · 22108237 (PubMed) · PMC3237759 (PubMed Central)
  9. Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus. Lertnawapan R, Bian A, Rho YH, Raggi P, Oeser A, Solus JF, Gebretsadik T, Shintani A, Stein CM (2012) Lupus 21(3): 279-87
    › Primary publication · 22072023 (PubMed) · PMC3275887 (PubMed Central)
  10. ADHD drugs and serious cardiovascular events in children and young adults. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (2011) N Engl J Med 365(20): 1896-904
    › Primary publication · 22043968 (PubMed) · PMC4943074 (PubMed Central)
View full member profile

Featured Affiliation

View all affiliations

Contact Information

No address provided
63420 (p)
Email

Keywords & MeSH Terms

MeSH terms are retrieved from PubMed records. Learn more.

Key: MeSH Term Keyword

Administration, Cutaneous Adrenal Cortex Hormones Analysis of Variance Calcium Channel Blockers Central Nervous System Stimulants Digoxin Drug Combinations Drug Resistance Edema Estrogens Follow-Up Studies Gastrointestinal Tract Health Care Reform HIV Seropositivity HLA-B Antigens Interleukin-1 Introns Neoplasms Patient Selection Phenylephrine Phosphodiesterase Inhibitors Placebos Plethysmography Primary Health Care Randomized Controlled Trials as Topic Receptors, Drug Reference Standards Rheumatic Diseases Urban Population Vascular Resistance